This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
This is a test.
ES2 trial: combining a PARP inhibitor and apoptosis sensitizer
This is a test.
Building a scientific toolbox to study low-grade serous ovarian cancer
This is a test.
Every Woman Study: Canadian Edition
This is a test.
Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor
This is a test.
NEOCATS trial: Targeting the targets with a combination of three treatments
This is a test.
Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor
This is a test.
A novel model system to study ovarian cancer/immune cell interactions
